Nomura Holdings’s Arvinas ARVN Stock Holding History

Nomura Holdings’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-70,000	Closed	-$491K	–	1451
2025 Q1	$491K	Buy	70,000 +40,000	+133%	+$627K	﹤0.01%	1488
2024 Q4	$575K	Buy	+30,000	New	+$729K	﹤0.01%	1734

Other funds holding ARVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nomura Holdings's ARVN Position: Q2 2026 in Review

Nomura Holdings sold out of Arvinas (ARVN) in Q2 2026, closing a stake of 253,609 shares — an estimated $2.69M sold.

Nomura Holdings first reported a position in ARVN in Q3 2020 and held it in 11 quarters. The position peaked at $31.3M in Q4 2020. 201 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

Nomura Holdings reported no remaining Arvinas position as of Q2 2026 after selling out during the quarter.
Nomura Holdings sold 253,609 Arvinas shares in Q2 2026, an estimated $2.69M.
Nomura Holdings first reported a position in Arvinas in Q3 2020 and held it in 11 quarters.
Nomura Holdings's Arvinas position peaked at $31.3M in Q4 2020.
201 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.